Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trolamine salicylate is a topical analgesic classified as a non-steroidal anti-inflammatory drug (NSAID). It is widely used for the temporary relief of minor aches and pains in muscles and joints, including those associated with arthritis, backache, muscle strains, sprains, and bruises. The drug works by penetrating the skin and inhibiting cyclooxygenase (COX) enzymes, which are responsible for the synthesis of prostaglandins, key mediators of pain and inflammation. A notable characteristic of trolamine salicylate is its lack of odor, distinguishing it from some other topical analgesics. It is available over-the-counter in various topical formulations such as creams, lotions, and sprays.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Trolamine salicylate.